X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/29/2837977/19782/en/CytoDyn-Announces-FDA-Has-Lifted-Clinical-Hold.html
https://www.fiercebiotech.com/biotech/cytodyn-finally-clears-fda-hold-hiv-program-after-two-years
https://www.globenewswire.com//news-release/2024/02/01/2821970/19782/en/CytoDyn-Announces-Submission-of-Clinical-Protocol-to-FDA-and-Initiation-of-Pre-Clinical-Study-in-Glioblastoma.html
https://www.globenewswire.com/news-release/2024/01/29/2818905/19782/en/CytoDyn-Appoints-Jacob-Lalezari-M-D-as-CEO-Mitchell-Cohen-as-Interim-CFO.html
https://www.globenewswire.com//news-release/2023/12/07/2792877/0/en/Zealand-Pharma-Increases-its-Share-Capital-as-a-Consequence-of-Exercise-of-Employee-Warrants.html
https://www.globenewswire.com//news-release/2023/11/21/2784054/19782/en/CytoDyn-Appoints-Jacob-Lalezari-M-D-as-Interim-CEO.html
https://www.globenewswire.com//news-release/2023/11/03/2773434/19782/en/November-2023-Letter-to-Shareholders.html
https://www.globenewswire.com/news-release/2023/07/11/2703127/19782/en/CytoDyn-Announces-Company-Updates-and-Investment-Community-Update-Webcast.html
https://www.globenewswire.com/news-release/2023/05/24/2675727/19782/en/CytoDyn-Announces-President-Takes-Medical-Leave-of-Absence.html
https://www.globenewswire.com/news-release/2023/04/05/2641690/19782/en/CytoDyn-to-Hold-Webcast-to-Provide-a-Company-Update.html
Market Place
Share 
